Assessment of soluble epoxide hydrolase activity in vivo: A metabolomic approach
Authors:
- 10 January 2020
- journal article
- conference paper
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 148, 106410
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- American Diabetes Association
This publication has 26 references indexed in Scilit:
- Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular diseaseAtherosclerosis, 2012
- Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia‐reperfusion injury in isolated mouse heartThe FASEB Journal, 2011
- Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistanceProceedings of the National Academy of Sciences, 2011
- Genetic Variation in Soluble Epoxide Hydrolase ( EPHX2 ) Is Associated With Forearm Vasodilator Responses in HumansHypertension, 2011
- Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approachesJournal of Molecular and Cellular Cardiology, 2009
- Quantitative Profiling Method for Oxylipin Metabolome by Liquid Chromatography Electrospray Ionization Tandem Mass SpectrometryAnalytical Chemistry, 2009
- Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophyProceedings of the National Academy of Sciences, 2009
- Hydrolysis of cis- and trans- Epoxyeicosatrienoic Acids by Rat Red Blood CellsThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Genetic variation in cytochrome P450 2J2 and soluble epoxide hydrolase and risk of ischemic stroke in a Chinese populationPharmacogenetics and Genomics, 2008
- Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitorsProceedings of the National Academy of Sciences, 2006